These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6616781)

  • 1. Action of sotalol on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs in the late postmyocardial infarction phase.
    Cobbe SM; Hoffman E; Ritzenhoff A; Brachmann J; Kübler W; Senges J
    Circulation; 1983 Oct; 68(4):865-71. PubMed ID: 6616781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta receptor blockade potentiates the antiarrhythmic actions of d-sotalol on reentrant ventricular tachycardia in a canine model of myocardial infarction.
    Kassotis J; Sauberman RB; Cabo C; Wit AL; Coromilas J
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1233-44. PubMed ID: 14678141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological mechanisms of action of the levorotatory isomer of sotalol in a canine infarct model of inducible ventricular tachycardia: comparison with the beta-1 receptor antagonist bisoprolol.
    Aidonidis I; Rizos I; Hilbel T; Kuebler W; Brachmann J
    J Mol Cell Cardiol; 1994 Jul; 26(7):841-8. PubMed ID: 7966352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of disopyramide on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs during the late post-myocardial infarction phase.
    Cobbe SM; Hoffmann E; Ritzenhoff A; Brachmann J; Kübler W; Senges J
    Am J Cardiol; 1984 Jun; 53(11):1712-8. PubMed ID: 6731317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of delayed ventricular repolarization to the anti-arrhythmic efficacy of sotalol.
    Brachmann J; Senges J; Lengfelder W; Jauernig R; Rizos I; Czygan E; Cobbe SM; Kübler W
    Eur Heart J; 1985 Nov; 6 Suppl D():171-4. PubMed ID: 3936715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bepridil versus nifedipine for ventricular tachycardia induced in the late postinfarction phase in conscious dogs.
    Brachmann J; Aidonidis I; Dembowsky K; Seller H; Kuebler W
    Cardiology; 1989; 76(3):211-21. PubMed ID: 2789099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
    Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
    Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
    Franz MR; Gray RA; Karasik P; Moore HJ; Singh SN
    Europace; 2014 Nov; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol.
    Patterson E; Lynch JJ; Lucchesi BR
    J Pharmacol Exp Ther; 1984 Aug; 230(2):519-26. PubMed ID: 6086892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dispersion of ventricular refractoriness in experimental myocardial infarction: effect of sotalol.
    Lubiński A; Hindricks G; Shenasa M; Haverkamp W; Vogt B; Borggrefe M; Breithardt G
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2090-4. PubMed ID: 7845823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol.
    Lynch JJ; Wilber DJ; Montgomery DG; Hsieh TM; Patterson E; Lucchesi BR
    J Cardiovasc Pharmacol; 1984; 6(6):1132-41. PubMed ID: 6084771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
    Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction.
    Drexler AP; Micklas JM; Brooks RR
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):848-55. PubMed ID: 8961084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ibutilide on spontaneous and induced ventricular arrhythmias in 24-hour canine myocardial infarction: a comparative study with sotalol and encainide.
    Buchanan LV; Kabell G; Turcotte UM; Brunden MN; Gibson JK
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):256-63. PubMed ID: 1376795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological mechanisms of action of ethmozine that explain its antiarrhythmic efficacy in the late stage of experimental myocardial infarction in dogs.
    Aidonidis I; Egel E; Hilbel T; Rizos I; Kuebler W; Brachmann J
    Eur Heart J; 1994 Dec; 15(12):1698-704. PubMed ID: 7698141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of electrophysiological mechanisms of anti-arrhythmia III class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation].
    Kaverina NV; Lyskovtsev VV; Popova EP
    Eksp Klin Farmakol; 2003; 66(1):27-33. PubMed ID: 12683077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sotalol.
    Hohnloser SH; Woosley RL
    N Engl J Med; 1994 Jul; 331(1):31-8. PubMed ID: 8202100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological effects of flecainide on anisotropic conduction and reentry in infarcted canine hearts.
    Coromilas J; Saltman AE; Waldecker B; Dillon SM; Wit AL
    Circulation; 1995 Apr; 91(8):2245-63. PubMed ID: 7697855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.